These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11377405)

  • 1. Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors.
    Cavallini L; Francesconi MA; Zoccarato F; Alexandre A
    Biochem Pharmacol; 2001 Jul; 62(1):141-7. PubMed ID: 11377405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin.
    Cianferoni A; Schroeder JT; Kim J; Schmidt JW; Lichtenstein LM; Georas SN; Casolaro V
    Blood; 2001 Mar; 97(6):1742-9. PubMed ID: 11238116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the c-jun N-terminal kinase/activator protein-1 pathway.
    Fürst R; Blumenthal SB; Kiemer AK; Zahler S; Vollmar AM
    J Pharmacol Exp Ther; 2006 Jul; 318(1):389-94. PubMed ID: 16624973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
    Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB.
    Koch E; Klaas CA; Rüngeler P; Castro V; Mora G; Vichnewski W; Merfort I
    Biochem Pharmacol; 2001 Sep; 62(6):795-801. PubMed ID: 11551526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
    Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
    J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase.
    Bradbury CM; Markovina S; Wei SJ; Rene LM; Zoberi I; Horikoshi N; Gius D
    Cancer Res; 2001 Oct; 61(20):7689-96. PubMed ID: 11606413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory function of 4-tert-butylphenyl salicylate through down-regulation of the NF-kappa B pathway.
    Choi YH; Na BH; Choi YS; Saifur Rahman M; Kim MR; Jee JP; Shin J; Suh JW; Yoo JC
    Arch Pharm Res; 2016 Mar; 39(3):429-36. PubMed ID: 26849878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration.
    Pierce JW; Read MA; Ding H; Luscinskas FW; Collins T
    J Immunol; 1996 May; 156(10):3961-9. PubMed ID: 8621937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of salicylates on lymphocyte blastogenesis in vitro: association with other non-steroid anti-inflammatory drugs.
    Conti P; Cifone MG; Alesse E; Ianni G; Angeletti PU
    Clin Rheumatol; 1983 Jun; 2(2):127-32. PubMed ID: 6678687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid.
    Mitchell JA; Saunders M; Barnes PJ; Newton R; Belvisi MG
    Mol Pharmacol; 1997 Jun; 51(6):907-12. PubMed ID: 9187256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of aspirin and sodium salicylate.
    Amann R; Peskar BA
    Eur J Pharmacol; 2002 Jun; 447(1):1-9. PubMed ID: 12106797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R; Sharma D; Sandur SK; Khanam S; Poduval TB
    Int Immunopharmacol; 2009 Jul; 9(7-8):949-58. PubMed ID: 19374955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of salicylideneamino-2-thiophenol on NF-κB signaling cascade and cyclooxygenase-2 in HNE-treated endothelial cells.
    Park S; Sung B; Jang EJ; Kim DH; Park CH; Choi YJ; Ha YM; Kim MK; Kim ND; Yu BP; Chung HY
    Arch Pharm Res; 2013 Jul; 36(7):880-9. PubMed ID: 23604717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
    Wahl C; Liptay S; Adler G; Schmid RM
    J Clin Invest; 1998 Mar; 101(5):1163-74. PubMed ID: 9486988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of acetylsalicylic acid in giant cell arteritis.
    Weyand CM; Kaiser M; Yang H; Younge B; Goronzy JJ
    Arthritis Rheum; 2002 Feb; 46(2):457-66. PubMed ID: 11840449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin and salicylate suppress polymorphonuclear apoptosis delay mediated by proinflammatory stimuli.
    Negrotto S; Malaver E; Alvarez ME; Pacienza N; D'Atri LP; Pozner RG; Gómez RM; Schattner M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):972-9. PubMed ID: 16936242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors.
    Iñiguez MA; Punzón C; Cacheiro-Llaguno C; Díaz-Muñoz MD; Duque J; Cuberes R; Alvarez I; Andrés EM; Buxens J; Buschmann H; Vela JM; Fresno M
    Int Immunopharmacol; 2010 Oct; 10(10):1295-304. PubMed ID: 20709632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.